Table 3.

Prevalence of major depressive disorder and anxiety disorders, by super-region, 2020

	Major depressive disorder, per 100 000 population				Anxiety disorders, per 100 000 population
	Baseline (95% UI)	Additional (95% UI)	Final (95% UI)	Percentage change (95% UI)	Baseline (95% UI)	Additional (95% UI)	Final (95% UI)	Percentage change (95% UI)
Global	2470·5 (2143·5–2870·7)	682·4 (574·1–807·2)	3152·9 (2722·5–3654·5)	27·6 (25·1–30·3)	3824·9 (3283·3–4468·1)	977·5 (824·8–1161·6)	4802·4 (4108·2–5588·6)	25·6 (23·2–28·0)
Central Europe, eastern Europe, and central Asia	2519·7 (2185·0–2911·5)	741·6 (579·1–941·3)	3261·3 (2798·6–3804·8)	29·4 (23·9–35·8)	3274·3 (2801·2–3821·9)	981·0 (774·1–1214·4)	4255·3 (3593·1–4970·8)	30·0 (24·9–35·0)
High-income	3103·3 (2735·6–3526·4)	840·1 (671·7–1030·4)	3943·3 (3466·9–4516·1)	27·1 (22·6–31·5)	5356·8 (4609·1–6233·3)	1349·0 (1044·1–1678·8)	6705·7 (5773·4–7829·4)	25·2 (20·3–30·7)
Latin America and Caribbean	2626·8 (2291·4–3034·4)	914·2 (737·4–1127·5)	3541·0 (3063·3–4097·7)	34·8 (29·5–40·7)	5705·9 (4865·4–6732·9)	1804·1 (1425·8–2225·1)	7510·0 (6397·9–8786·6)	31·7 (25·8–37·7)
North Africa and Middle East	3321·4 (2752·3–4013·2)	1235·2 (896·1–1642·5)	4556·6 (3729·1–5578·3)	37·2 (29·5–46·0)	5148·9 (4210·4–6289·4)	1664·8 (1178·0–2251·6)	6813·6 (5557·9–8391·8)	32·4 (24·9–41·1)
South Asia	2664·2 (2313·9–3099·5)	962·6 (761·6–1187·1)	3626·8 (3122·5–4232·7)	36·1 (29·7–42·8)	3019·7 (2590·4–3531·6)	1058·3 (813·0–1318·7)	4077·9 (3459·3–4786·7)	35·1 (28·2–42·0)
Southeast Asia, east Asia, and Oceania	1707·8 (1492·4–1958·7)	195·8 (121·8–281·4)	1903·6 (1656·1–2194·3)	11·5 (7·2–16·0)	3367·2 (2903·3–3891·5)	466·0 (307·2–632·0)	3833·2 (3281·8–4478·2)	13·8 (9·3–18·3)
Sub-Saharan Africa	2429·0 (2048·0–2910·2)	559·0 (423·3–722·8)	2988·0 (2513·5–3583·4)	23·0 (18·3–27·9)	3001·9 (2465·1–3671·3)	644·0 (479·0–829·9)	3645·9 (2985·7–4475·5)	21·5 (17·1–25·7)

UI=uncertainty interval.